Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • Oasis IVF Hospitals...

    Oasis IVF Hospitals raises Rs 40 crores in funding

    Written by savita thakur thakur Published On 2016-10-13T11:53:50+05:30  |  Updated On 16 Aug 2021 1:29 PM IST

    Hyderabad: Oasis Centre for Reproductive Medicine, one of the leading chains of in-vitro fertilisation (IVF) centres, announced that it has raised $6.2 million (Rs.40 crore) from India Life Sciences Fund II.


    The investment will help the company in establishing more centres in the country and introducing advanced assisted reproductive technology (ART) for infertility treatments, the company said in a statement. This will also allow the six-year-old company to focus on creating value for all the stakeholders and setting a benchmark for the industry.


    Founded in Hyderabad in 2009 by renowned infertility specialist Durga G Rao and seasoned entrepreneur Kiran Gadela, Oasis is recognised as the trusted provider of advanced fertility treatments, providing a unique blend of high-level medical expertise and personalised management to couples seeking fertility treatment, the statement said.


    The IVF market is predicted to grow at a CAGR of 10.1 percent in the next five years to reach Rs 5,027.57 crore ($756 million) by 2021, according to a research report by MarketsandMarkets.


    "Oasis is poised for a good growth with Dr. Durga Rao bringing in the medical expertise and Kiran Gadela's entrepreneurial skills. I am pleased to join the Oasis' board as a director," said Anula K.Jayasuriya, Managing Director, InvAscent, the investment advisor to EILSF (Evolvence IndiaLife Sciences Fund) and India Life Sciences Fund II.


    "Since inception, Oasis' key focus has been to establish a centre of excellence with transparent, ethical and evidence-based practice to treat infertility," said Gadela, co-founder and Managing Director at Oasis.

    IVFMarketsandMarketsnvAscentOasis CentreOasis Centre for Reproductive Medicine
    Source : IANS

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    savita thakur thakur
    savita thakur thakur
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok